Financial statements Bit Molecule
Company suspended its operations from 2024-12-31
Balance sheet data of BIT MOLECULE
Year
|
2022
|
---|---|
Total assets | 88 891,32 |
A. Fixed assets | 37 773,75 |
B. Current assets | 51 117,57 |
C. Share capital contributions (basic funds) | - |
D. Own shares (stocks) | - |
Total liabilities | 88 891,32 |
A. Equity | -114 216,44 |
B. Liabilities and provisions for liabilities | 203 107,76 |
I. Long-term liabilities | - |
II. Short-term liabilities | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.